StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$48.06M. The highest annual figure on record is -$26.96M in fiscal 2023.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$48.06M–
FY2024Dec 31, 2024-$39.26M–
FY2023Dec 31, 2023-$26.96M–
FY2022Dec 31, 2022-$41.01M–
FY2021Dec 31, 2021-$36.65M–
FY2020Dec 31, 2020-$48.29M–

More CASI Pharmaceuticals figures

See a number that looks wrong?